Investor Presentaiton

We are leveraging expertise to enable expansion beyond Hematology while increasing manufacturing efficiency Wave 1 Single CAR binder Wave 2 Dual CAR binder Wave 3 Multiple other KO/KI Dual CAR binder TCR KO Next-gen engineering Evolving delivery systems Optimizing manufacturing Ill Bristol Myers Squibb™ MHC-I KO MHC-II KO Monospecific CAR Dual Targeting CAR Engineered CAR/TCR Not for Product Promotional Use 42

View entire presentation